Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population

Genes and Immunity

Volumn 2, Issue 1, 2001, Pages 44-47

  Aithal, G P ^a,b   Day, C P ^a   Leathart, J ^a   Daly, A K ^a   Hudson, M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Interleukin 4; Interleukin 4 receptor; Ulcerative colitis

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PRIMER DNA;

ARTICLE; CROHN DISEASE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

BASE SEQUENCE; CROHN DISEASE; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INTERLEUKIN-4; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-4;

EID: 0035260923     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363730     Document Type: Article

References (36)

1. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-539.
2. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-642.
3. Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behaviour in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-1853.
4. Takahashi I, Kiyono H, Hamada S. CD4+ T cell population mediates development of inflammatory bowel disease in T cell receptor α chain-deficient mice. Gastroenterology 1997; 112: 1876-1886.
5. Iijima H, Takahashi I, Kishi D et al. Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med 1999; 190: 607-616.
6. Mizoguchi A, Mizoguchi E, Bhan AK. The critical role of interleukin-4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor α mutant mice. Gastroenterology 1999; 116: 320-326.
7. Margolin K, Aronson FR, Sznol M et al. Phase II studies of recombinant interleukin-4 in advanced renal cancer and malignant melanoma. J Immunother 1994; 15: 147-153.
8. Desreumaux P, Brandt E, Gambiez L et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 1997; 113: 118-126.
9. Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD. Interleukin-4 and high levels of transforming growth factors and receptors are deleted in myeloid leukaemia with del (5q). Blood 1989; 73: 647-650.
10. Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25 (Suppl 2): 74-78.
11. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997; 156: 5152-5155.
12. Kawashima T, Noguchi E, Arinami T el al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998; 35: 229-239.
13. Noguchi E, Shibasaki M, Arinami T et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998; 28: 449-453.
14. Cantagrel A, Navaux F, Loubet-Lescoulie P et al. Interleukin-1β, Interleukin-1 receptor antagonist, Interleukin-4, and Interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-1100.
15. Walley AJ, Cookson WOCM. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 1996; 33: 689-692.
16. Takabayashi A, Ihara K, Sasaki Y, Kusuhara K, Nishima S, Hara T. Novel polymorphism in the 5′-untranslated region of the interleukin-4 gene. J Hum Genet 1999; 44: 352-353.
17. Suzuki I, Yamaguchi E, Hizawa N, Itoh A, Kawakami Y. A new polymorphism in the 5′ flanking region of the human interleukin IL-4 gene. Immunogenetics 1999; 49: 738-739.
18. Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 receptor and its correlation with atopy. Int J Mol Med 1999; 3: 3-10.
19. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signalling mechanisms and biologic functions. Ann Rev Immunol 1999; 17: 701-738.
20. Shirakawa T, Deichmann KA, Izuhara K, Mao X-Q, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunology Today 2000; 21: 60-64.
21. Khorana Hershey G, Fredrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain of function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720-1725.
22. Ober C, Leavitt SA, Tsalenko A et al. Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66: 517-526.
23. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823.
24. Rioux JD, Silverberg MS, Daly MJ et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870.
25. Olavesen MG, Hampe J, Mirza MM et al. Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease. Immunogenetics 2000; 51: 1-7.
26. Daly AK, Steen VM, Fairbrother KS, Idle JR. CYP2D6 multi-allelism. Methods Enzymol 1996; 272: 199-210.
27. Vajdy M, Kosco-Vilbois MH, Kopf M, Kohler G, Lycke N. Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 1995; 181: 41-53.
28. Hermon-Taylor J. Causation of Crohn's disease: the impact of clusters. Gastroenterology 1993; 104: 643-646.
29. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-1621.
30. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-1404.
31. Iizawa Y, Wagner D, Czuprynski CJ. Analysis of cytokine mRNA expression in Listeria-resistant C57BL/6 and Listeria-susceptible A/J mice during Listeria monocytogenes infection. Infect Immun 1993; 61: 3739-3744.
32. Colgan SP, Resnick MB, Parkos CA et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 1994; 153: 2122-2129.
33. Radford-Smith G. Ulcerative colitis: an immunological disease? Balliere's Clin Gastroenterol 1997; 11: 35-52.
34. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesise elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 1992; 90: 1479-1485.
35. Sempowski GD, Derdak S, Phipps RP. Interleukin-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996; 167: 290-296.
36. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-10668.